Moderna Halts Vaccine Trial Over ‘Adverse Event’

Adverse event was reportedly myocarditis.

Moderna's headquarters in Cambridge, Mass., on May 8, 2020. Maddie Meyer/Getty Images

Moderna halted a clinical trial for a new vaccine because one of the participants suffered an adverse event, The Epoch Times has confirmed.

Workers at two of the trial sites said the trial for the Epstein-Barr virus vaccine, which launched in early 2022, was paused.